|1||NCT02971683||Recruiting||Trial to Evaluate the Efficacy and Safety of Abatacept in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy||
||150||All||18 Years and older (Adult, Older Adult)||NCT02971683||IM101-611
|March 13, 2017||June 17, 2020||June 18, 2021||November 23, 2016||July 11, 2018||
|2||NCT02594735||Recruiting||Abatacept in Juvenile Dermatomyositis||
||10||All||7 Years and older (Child, Adult, Older Adult)||NCT02594735||IRB 111418||AID||November 2015||December 2018||December 2018||November 3, 2015||September 6, 2018||
† Study has passed its completion date and status has not been verified in more than two years.